Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.

× No keyword cloud information.

7 in total

1. Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity.

Authors: R Wong; V V Vasilyev; Y T Ting; D I Kutler; M C Willingham; B D Weintraub; S Cheng
Journal: Mol Med Date: 1997-05 Impact factor: 6.354

Review 2. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.

Authors: Craig W Berridge; David M Devilbiss
Journal: Biol Psychiatry Date: 2010-09-26 Impact factor: 13.382

Review 3. Biological and social influences on cognitive control processes dependent on prefrontal cortex.

Authors: Adele Diamond
Journal: Prog Brain Res Date: 2011 Impact factor: 2.453

4. Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder.

Authors: Ji-Jun Li; Zai-Wang Li; Shu-Zhen Wang; Fang-Hua Qi; Lin Zhao; Hong Lv; An-Yuan Li
Journal: Psychopharmacology (Berl) Date: 2011-03-18 Impact factor: 4.530

Review 5. Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity).

Authors: Adele Diamond
Journal: Dev Psychopathol Date: 2005

Review 6. Treatment strategies for co-occurring ADHD and substance use disorders.

Authors: John J Mariani; Frances R Levin
Journal: Am J Addict Date: 2007

Review 7. Consequences of variations in genes that affect dopamine in prefrontal cortex.

Authors: Adele Diamond
Journal: Cereb Cortex Date: 2007-09 Impact factor: 5.357

7 in total